Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rESP vs EPO for anemia maintenance in hemodialysis CKD (Phase II)
CTR20190496Phase 2Completed
- Sponsor
- Shenyang Sansheng Pharmaceutical Co., Ltd.
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of SSS06 in anemia of renal disease, sponsored by Shenyang Sansheng Pharmaceutical Co., Ltd.. Started Apr 2019; status: completed.
02
Drugs
SSS06
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on CTR20190496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190496.